Eli Lilly, Novo Nordisk near deal on weight loss drug costs
Digest more
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its ...
Investor's Business Daily on MSN
Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled
Novo Nordisk stock reversed higher Wednesday, though the Wegovy and Ozempic maker cut its sales outlook for the third time ...
Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Novo Nordisk's (NVO) bidding ...
Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback